Bank Of America Corp Adicet Bio, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 70,438 shares of ACET stock, worth $88,047. This represents 0.0% of its overall portfolio holdings.

Number of Shares

70,438

Previous 101,999 30.94%

Holding current value

$88,047

Previous $239,000 64.44%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.21 - $2.4 $38,188 - $75,746	-31,561 Reduced 30.94%	70,438 $85,000
Q1 2024 May 15, 2024	BUY	$1.76 - $3.45 $95,490 - $187,183	54,256 Added 113.64%	101,999 $239,000
Q4 2023 Feb 14, 2024	BUY	$1.11 - $1.89 $15,272 - $26,004	13,759 Added 40.49%	47,743 $90,000
Q2 2023 Aug 14, 2023	SELL	$2.13 - $7.13 $9,090 - $30,430	-4,268 Reduced 11.16%	33,984 $82,000
Q1 2023 May 12, 2023	SELL	$5.52 - $9.23 $784,932 - $1.31 Million	-142,198 Reduced 78.8%	38,252 $220,000
Q4 2022 Feb 10, 2023	BUY	$7.72 - $21.27 $460,636 - $1.27 Million	59,668 Added 49.4%	180,450 $1.61 Million
Q3 2022 Nov 14, 2022	BUY	$13.43 - $18.74 $1.32 Million - $1.84 Million	98,146 Added 433.58%	120,782 $1.72 Million
Q2 2022 Aug 12, 2022	SELL	$10.26 - $20.81 $132,374 - $268,490	-12,902 Reduced 36.3%	22,636 $330,000
Q1 2022 May 16, 2022	SELL	$11.53 - $19.97 $434,911 - $753,268	-37,720 Reduced 51.49%	35,538 $710,000
Q4 2021 Feb 08, 2022	BUY	$7.37 - $17.49 $446,452 - $1.06 Million	60,577 Added 477.7%	73,258 $1.28 Million
Q3 2021 Nov 15, 2021	BUY	$6.29 - $9.93 $29,984 - $47,336	4,767 Added 60.24%	12,681 $99,000
Q2 2021 Sep 13, 2021	BUY	$9.19 - $15.93 $72,729 - $126,070	7,914 New	7,914 $82,000

Others Institutions Holding ACET

# of Institutions

Shares Held

66.3M

Call Options Held

4.3K

Put Options Held

36.3K

View Full List

About Adicet Bio, Inc.

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $50M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

More about ACET

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Adicet Bio, Inc. Transaction History